Ana Leticia Maragno

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

András Kotschy, Zoltán Szlávik, James B. Murray et al. · Nature · 2016 · 1.1K citations

Medicine, Oncology, Pharmacology +11

Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer

Delphine Mérino, James R. Whittle, François Vaillant et al. · Science Translational Medicine · 2017 · 192 citations

Medicine, Oncology, Pharmacology +14

Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia

Donia M. Moujalled, Giovanna Pomilio, Corina Ghiurau et al. · Leukemia · 2018 · 174 citations · Full text

Medicine, Oncology, Pharmacology +17

Time course of skeletal muscle loss and oxidative stress in rats with walker 256 solid tumor

Flávia Alessandra Guarnier, Alessandra Lourenço Cecchini, Andréia Akemi Suzukawa et al. · Muscle & Nerve · 2010 · 74 citations

Life Sciences, Biochemistry, Oncology +17

Testosterone represses ubiquitin ligases atrogin-1 and Murf-1 expression in an androgen-sensitive rat skeletal muscle in vivo

Marcelo Pires-Oliveira, Ana Leticia Maragno, Lucas T. Parreiras‐e‐Silva et al. · Journal of Applied Physiology · 2009 · 63 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17